Insider Trading Activity Biogen Inc. (NASDAQ:BIIB) – EVP Sold 7,758 shares of Stock

ME Staff
-
0

Insider Trading Activity For Biogen Inc. (NASDAQ:BIIB)

Susan H Alexander , EVP of Biogen Inc. (NASDAQ:BIIB) reportedly Sold 7,758 shares of the company’s stock at an average price of 285 for a total transaction amount of $2,211,030.00 SEC Form

Insider Trading History For Biogen Inc. (NASDAQ:BIIB)

  • On 12/27/2012 Alexander J Denner, Director, sold 7,980 with an average share price of $148.62 per share and the total transaction amounting to $1,185,987.60.View SEC Filing
  • On 5/28/2013 Robert W Pangia, Director, sold 5,900 with an average share price of $237.23 per share and the total transaction amounting to $1,399,657.00.View SEC Filing
  • On 6/3/2013 Stephen A Sherwin, Director, sold 12,825 with an average share price of $233.26 per share and the total transaction amounting to $2,991,559.50.View SEC Filing
  • On 6/3/2013 George A Scangos, CEO, sold 1,598 with an average share price of $234.16 per share and the total transaction amounting to $374,187.68.View SEC Filing
  • On 6/10/2013 Lynn Schenk, Director, sold 2,000 with an average share price of $225.82 per share and the total transaction amounting to $451,640.00.View SEC Filing
  • On 6/11/2013 Brian S Posner, Director, sold 2,020 with an average share price of $219.62 per share and the total transaction amounting to $443,632.40.View SEC Filing
  • On 6/14/2013 Alexander J Denner, Director, sold 2,900 with an average share price of $212.00 per share and the total transaction amounting to $614,800.00.View SEC Filing

    • Analyst Ratings For Biogen Inc. (NASDAQ:BIIB)
    These are 11 Hold Ratings, 12 Buy Ratings, 1 Strong Buy Rating .
    The current consensus rating for Biogen Inc. (NASDAQ:BIIB) is Buy (Score: 2.58) with a consensus target price of $327.76 , a potential (16.46% upside)

    Analyst Ratings History For Biogen Inc. (NASDAQ:BIIB)

    • On 7/27/2015 Argus Lower Price Target of rating Buy with a price target of $450.00 to $360.00
    • On 9/23/2015 Oppenheimer Holdings, Inc. Reiterated Rating Sector Perform
    • On 12/18/2015 Atlantic Securities Initiated Coverage of rating Overweight with a price target of $344.00
    • On 4/23/2016 Goldman Sachs Group, Inc. (The) Reiterated Rating Hold
    • On 6/8/2016 Wells Fargo & Company Reiterated Rating Buy
    • On 8/2/2016 Standpoint Research Downgraded rating Buy to Hold
    • On 9/22/2016 Bank of America Corporation Reiterated Rating Buy with a price target of $374.00

    Recent Trading Activity for Biogen Inc. (NASDAQ:BIIB)
    Shares of Biogen Inc. closed the previous trading session at 281.44 down -0.51 -0.18% with 1,027,873 shares trading hands.